The study suggests that the viral capsid protein gamma acts as a proteolytic enzyme involved in the maturation of the encephalomyocarditis virus capsid precursor.
Answers are grounded in this paper and cite their sources.
Suggests gamma protein mediates EMCV precursor cleavage; leaves open applicability to human picornavirus infections.
Translation of encephalomyocarditis virus RNA in a cell-free system from uninfected Krebs ascites cells results in the synthesis of a major polypeptide product with a molecular weight of approximately 112,000. In contrast, when the viral RNA is translated in a cell-free system from virus-infected cells, this polypeptide is absent and the largest polypeptide produced has a molecular weight of about 100,000. This latter polypeptide comigrates on sodium dodecyl sulfate-gels with in vivo virus capsid precursor A, and the two have identical patterns of CNBr-generated peptides. A polypeptide having a molecular weight of 12,500 is also a major translation product in the system from infected cells (but not from uninfected cells). This polypeptide appears to be generated by cleavage of the NH-2-terminal portion of the viral RNA-dependent polypeptides by a proteolytic activity present in the infected cell-free system. This proteolytic activity copurifies with the 23,000-molecular weight viral capsid protein gamma, found in infected cells, through chromatography on DEAE-cellulose and cellulose phosphate. This suggests that gamma is itself a proteolytic enzyme involved in maturation of the viral capsid precursor.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: